Medicare may test policy of paying less for accelerated approval drugs

Stat News

31 January 2023 - Medicare official hinted Tuesday that Medicare might test a policy of paying less for drugs that receive so-called accelerated approvals than for drugs that are granted traditional approvals.

The FDA uses accelerated approvals to make promising drugs for serious conditions available to patients sooner.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder